IBRX Operating Expenses

Immunitybio Inc · Operating Expenses

IBRX logo

IBRX Operating Expenses

Latest reported$112.64M
IBRX Quarterly Operating Expenses ($84.17M → $112.64M)
High-resolution chart · PNG

IBRX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
112,639,000
113,759,000
98,721,000
83,563,000
97,574,000
80,888,000
76,952,000
86,359,000
100,380,000
95,236,000
85,528,000
80,218,000
85,186,000
105,662,000
77,414,000
84,947,000
73,726,000
90,578,000
79,664,000
78,902,000
86,245,000
86,403,000
28,660,000
66,028,000
51,352,000
36,867,000
21,519,000
16,077,000
17,313,000
18,340,000
17,726,000
24,139,000
28,282,000
28,289,000
25,406,000
24,450,000
23,834,000
25,475,000
25,158,000
32,787,000
34,977,000
31,595,000
79,937,000
42,804,000
84,174,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.